Skip to content

Latest medicine updates

112 updates found

New New Updated Updated Retired Retired

NARROW IT DOWN

MEDICINE NAME

CHANGES

Date range

DOCUMENT TYPE

STATUS

SPC
mesalazine
Updated 8-Dec-17
Updated
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
diclofenac diethylammonium
Updated 8-Dec-17
New
  • New individual SPC (was previously included in joint SPC)
SPC
diclofenac diethylammonium
Updated 8-Dec-17
New
  • New individual SPC (was previously included in joint SPC)
SPC
diclofenac diethylammonium
Updated 8-Dec-17
New
  • New individual SPC (was previously included in joint SPC)
SPC
aciclovir
Updated 8-Dec-17
Updated
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
SPC
aciclovir
Updated 8-Dec-17
Updated
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
SPC
aciclovir
Updated 8-Dec-17
Updated
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
SPC
terbutaline sulfate
Updated 8-Dec-17
Updated
  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text
SPC
fluticasone propionate, salmeterol xinafoate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 10 - Date of revision of the text
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
epoetin beta
Updated 8-Dec-17
Updated
  • Change to section 8 - Marketing authorisation number(s)
  • Correction of spelling/typing errors
SPC
sodium alginate, sodium bicarbonate, calcium carbonate
Updated 8-Dec-17
Updated
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text
SPC
triamcinolone acetonide
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text
SPC
nystatin
Updated 8-Dec-17
Updated
  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text
SPC
human normal immunoglobulin
Updated 8-Dec-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
  • Change to section 4.8 - Undesirable effects - how to report a side effect
Pil
testosterone
Updated 8-Dec-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
Pil
ethinylestradiol, desogestrel
Updated 8-Dec-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - what you need to know - contraindications
Pil
agalsidase alfa
Updated 8-Dec-17
Updated
  • Change to section 6 - date of revision
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - manufacturer
SPC
human normal immunoglobulin
Updated 8-Dec-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
amisulpride
Updated 8-Dec-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
amisulpride
Updated 8-Dec-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
amisulpride
Updated 8-Dec-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
amisulpride
Updated 8-Dec-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
pramipexole dihydrochloride monohydrate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
amisulpride
Updated 8-Dec-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
amisulpride
Updated 8-Dec-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
Pil
terazosin monohydrochloride dihydrate
Updated 8-Dec-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - what you need to know - contraindications
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - how to take/use
  • Change to section 1 - what the product is used for
  • Change to section 3 - use in children/adolescents
Pil
baricitinib
Updated 8-Dec-17
Updated
  • Change to section 6 - date of revision
  • Change to other sources of information section
Pil
triamcinolone acetonide
Updated 8-Dec-17
Updated
  • Change to section 6 - date of revision
  • Change to section 6 - marketing authorisation holder
SPC
amisulpride
Updated 8-Dec-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
amisulpride
Updated 8-Dec-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
dexamethasone sodium phosphate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
dexamethasone sodium phosphate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
dexamethasone sodium phosphate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
metformin hydrochloride
Updated 8-Dec-17
Updated
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text
SPC
metformin hydrochloride
Updated 8-Dec-17
Updated
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text
SPC
metformin hydrochloride
Updated 8-Dec-17
Updated
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text
SPC
dexrazoxane hydrochloride
Updated 8-Dec-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text
SPC
calcium carbonate, colecalciferol; cholecalciferol
Updated 8-Dec-17
Updated
  • Change to section 10 - Date of revision of the text
Pil
simvastatin
Updated 8-Dec-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - what you need to know - contraindications
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 2 - interactions with other medicines, food or drink
SPC
etanercept
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
SPC
etanercept
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
SPC
saxagliptin hydrochloride, dapagliflozin propanediol monohydrate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text
  • Removal of black triangle
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
pramipexole dihydrochloride monohydrate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
pramipexole dihydrochloride monohydrate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
pramipexole dihydrochloride monohydrate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
SPC
pramipexole dihydrochloride monohydrate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
SPC
pramipexole dihydrochloride monohydrate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
pramipexole dihydrochloride monohydrate
Updated 8-Dec-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
rifampicin, isoniazid
Updated 8-Dec-17
Updated
  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text
Pil
diclofenac diethylammonium
Updated 8-Dec-17
New
  • New PIL for new product

Page 1 of 3 Next

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue